DICE
T. Rowe Price Associates’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-64,449
| Closed | -$3M | – | 2939 |
|
|
2023
Q2 | $3M | Sell |
64,449
-3,190,981
| -98% | -$148M | ﹤0.01% | 1340 |
|
|
2023
Q1 | $93.3M | Buy |
3,255,430
+35,470
| +1% | +$1.02M | 0.01% | 524 |
|
|
2022
Q4 | $100M | Buy |
3,219,960
+666,503
| +26% | +$20.8M | 0.02% | 492 |
|
|
2022
Q3 | $51.8M | Buy |
2,553,457
+138,833
| +6% | +$2.82M | 0.01% | 638 |
|
|
2022
Q2 | $37.5M | Buy |
2,414,624
+270,940
| +13% | +$4.2M | ﹤0.01% | 974 |
|
|
2022
Q1 | $41M | Buy |
2,143,684
+390,893
| +22% | +$7.48M | ﹤0.01% | 1036 |
|
|
2021
Q4 | $44.4M | Buy |
1,752,791
+250,542
| +17% | +$6.34M | ﹤0.01% | 1050 |
|
|
2021
Q3 | $49.2M | Buy |
+1,502,249
| New | +$49.2M | ﹤0.01% | 1016 |
|